Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
![]() LUNGU, Lidia, ARICU, Aculina, CIOCARLAN, Alexandru, SHOVA, Sergiu, ZBANCIOC, Gheorghita N., MANGALAGIU, Ionel, VORNICU, Nicoleta. Synthesis, biological activity and X-ray analysis of 11,12-p-tolyl-pyridazonyl-drim-5(6),8(9)-en-7-one. In: Physical Methods in Coordination and Supramolecular Chemistry, 8-9 octombrie 2015, Chişinău. Chisinau, Republic of Moldova: 2015, XVIII, p. 93. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Physical Methods in Coordination and Supramolecular Chemistry XVIII, 2015 |
|||||||
Conferința ""Physical Methods in Coordination and Supramolecular Chemistry"" Chişinău, Moldova, 8-9 octombrie 2015 | |||||||
![]() |
|||||||
Pag. 93-93 | |||||||
|
|||||||
![]() |
|||||||
Rezumat | |||||||
The results of investigations devoted to the synthesis of new drimanic compound containing heterocyclic structural units are reported. The 11,12-p-tolyl-pyridazonyl-drim5(6),8(9)-en-7-one 3 was prepared by interaction of bromide 1 with p-tolyl-pyridazone 2 under depicted conditions.1 As result of “in vitro” biological assessment tested compound 3 showed exceptional activity against five strains of fungi (Aspergillus flavus, Fusarium solani, Penicillium chrysogenum, P. frequentans, Alternaria alternata) and against both Gram-positive (Bacillus polymyxa) and Gram-negative (Pseudomonas aeruginosa) bacteria at MIC values 510-3 μg/mL and 3.210-2 μg/mL, respectively.2figureScheme 1. Reagents and conditions: K2CO3, DMAA, r.t., 24h, 77%. The structure and stereochemistry of the compound 3 was confirmed unambiguously by X-ray diffraction on monocrystal (Figure 1). According to single crystal X-ray study compound 3 crystallizes in C2 space group of monoclinic system comprising two crystallographic asymmetric but chemically equivalent molecular entities (denoted A and B). One of the azaheterocyclic fragments in molecule A, as well as the whole molecule B, were found to be disordered into two resolvable positions in 1:1 ratio.3Figure 1. The X-ray molecular structure of compound 3. H atoms are omitted for clarity |
|||||||
|
Google Scholar Export
<meta name="citation_title" content="Synthesis, biological activity and X-ray analysis of 11,12-p-tolyl-pyridazonyl-drim-5(6),8(9)-en-7-one"> <meta name="citation_author" content="Lungu Lidia"> <meta name="citation_author" content="Aricu Aculina"> <meta name="citation_author" content="Ciocarlan Alexandru"> <meta name="citation_author" content="Shova Sergiu"> <meta name="citation_author" content="Zbancioc Gheorghita N."> <meta name="citation_author" content="Mangalagiu Ionel"> <meta name="citation_author" content="Vornicu Nicoleta"> <meta name="citation_publication_date" content="2015"> <meta name="citation_collection_title" content="Physical Methods in Coordination and Supramolecular Chemistry"> <meta name="citation_volume" content="XVIII"> <meta name="citation_firstpage" content="93"> <meta name="citation_lastpage" content="93"> <meta name="citation_pdf_url" content="https://ibn.idsi.md/sites/default/files/imag_file/093.pdf">